Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Antibody Targeting EGFR and LGR5, in Advanced HNSCC
Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecifi…
229 viewsMay 18, 2023
vumedi.com
Resistance Mechanisms and Sequencing for EGFR NSCLC | OncLive
Resistance Mechanisms and Sequencing for EGFR NSCLC | On…
Oct 23, 2018
onclive.com
Upfront EGFR-Targeted Therapy | OncLive
Upfront EGFR-Targeted Therapy | OncLive
Mar 18, 2016
onclive.com
Lung cancer study finds new target for treatment resistance after EGFR inhibitors | Newswise
Lung cancer study finds new target for treatment resistance after EGF…
Feb 10, 2023
newswise.com
Duality Biotherapeutics: First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
Duality Biotherapeutics: First Patient Dosed in Phase 1/2 Clinica…
8 months ago
finanznachrichten.de
GFR alpha-4 antibodies from Thermo Fisher Scientific
0:37
GFR alpha-4 antibodies from Thermo Fisher Scientific
5 months ago
thermofisher.com
Future Treatment Options in EGFR-Mutant NSCLC | OncLive
Future Treatment Options in EGFR-Mutant NSCLC | OncLive
11 months ago
onclive.com
Targeting HER3 in EGFR-Mutant NSCLC
Jun 16, 2023
onclive.com
Overcoming Resistance to EGFR Inhibitors in NSCLC | OncLive
Oct 20, 2018
onclive.com
0:32
Anti-Nephrin Antibodies | Invitrogen
Feb 12, 2023
thermofisher.com
Adjuvant EGFR Inhibition in Patients With NSCLC | OncLive
Feb 7, 2014
onclive.com
Treatment of TKI-Refractory EGFR-Mutant NSCLC | OncLive
2K viewsNov 12, 2021
onclive.com
ASCO® 2025 Summary: Targeting HER2 & EGFR Exon 20 in Advance…
168 views9 months ago
vumedi.com
4:04
Treatments and Unmet Needs for EGFR-Mutated NSCLC | OncLive
Oct 19, 2023
onclive.com
0:37
Anti-Claudin 4 Antibodies | Invitrogen
Feb 12, 2023
thermofisher.com
WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC
Feb 26, 2021
onclive.com
Refining EGFR Classifications and Impact on Treatment for NSCLC
Jul 14, 2023
onclive.com
0:33
Revisiting EGFR test results or retesting via next-generation sequ…
126.4K viewsJan 26, 2021
FacebookTakeda Oncology
ASCO® 2025 Insights: Sacituzumab Tirumotecan in Previously Treate…
66 views9 months ago
vumedi.com
3:58
Datopotamab Deruxtecan: A New ADC Option for EGFR-Mutated NS…
2 weeks ago
pharmacytimes.com
Mastering EGFR Testing and Targeted Therapy in Advanced NS…
7 months ago
reachmd.com
Future Directions in the Treatment of EGFR-mutated NSCLC: Academ…
Feb 27, 2025
targetedonc.com
Uncommon EGFR Mutations in NSCLC: Real-World Selection and …
Jul 21, 2023
onclive.com
Dr Rotow on the Investigation of ABBV-637 Plus Osimertinib in EG…
Oct 27, 2023
onclive.com
Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon …
Dec 18, 2024
reachmd.com
Dr Hassan on the CHRYSALIS trial of Amivantamab in EGFR Exon 20…
2 weeks ago
onclive.com
Role of Antibody-Drug Conjugates in NSCLC Treatment: Insights fro…
Jun 24, 2024
onclive.com
7:39
Precision Oncology and HIV Prevention Breakthroughs
1 views3 months ago
YouTubeOWITH
1:45
Advancements in Lung Cancer Treatment: The Impact of DATO-D…
24 views3 weeks ago
YouTubeOncUpdates: Latest Oncology Insights
Dr. Le on the Emergence of Antibody-Drug Conjugates in NSC…
Nov 15, 2021
onclive.com
See more videos
Static thumbnail place holder